TGF-β and Hepatocellular Carcinoma: When A Friend Becomes An Enemy

E-ISSN： 1875-5550|19|12|1172-1179

ISSN： 1389-2037

Source： Current Protein and Peptide Science, Vol.19, Iss.12, 2018-12, pp. : 1172-1179

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Dihydromyricetin Reduces TGF-β Via P53 Activation-dependent Mechanism in Hepatocellular Carcinoma HepG2 Cells

Protein and Peptide Letters, Vol. 24, Iss. 5, 2017-05 ,pp. : 419-424

Bentham Science Publishers

Access to resources Recommend Favorite

Epidemiology and Management of Acute Kidney Injury in Hepatocellular Carcinoma Patients Undergoing Transcatheter Arterial Chemoembolization

Current Protein and Peptide Science, Vol. 18, Iss. 12, 2017-10 ,pp. : 1218-1223

Bentham Science Publishers

Access to resources Recommend Favorite

Assessment of the Aggregation Propensity of the &bgr; -amyloid Peptide During the Synthesis and when Free in Solution

Protein and Peptide Letters, Vol. 20, Iss. 8, 2013-08 ,pp. : 848-855

Bentham Science Publishers

Access to resources Recommend Favorite

Comparison of the Structure and Biological Activities of Wild-type and Mutant Liver-targeting Peptide Modified Recombinant Human Endostatin (rES-CSP) in Human Hepatocellular Carcinoma HepG2 Cells

Protein and Peptide Letters, Vol. 22, Iss. 5, 2015-01 ,pp. : 470-479

Bentham Science Publishers

Access to resources Recommend Favorite

Poly(ADP-Ribose) Polymerases in Aging – Friend or Foe?

Current Protein and Peptide Science, Vol. 17, Iss. 7, 2016-09 ,pp. : 705-712

Bentham Science Publishers

Access to resources Recommend Favorite